Canine Oral Papillomatosis - Treatment with Association of Azithromycin and Meloxicam
DOI:
https://doi.org/10.22456/1679-9216.142719Keywords:
dog, papillomavirus, wart, diseaseAbstract
Background: Canine oral papillomatosis is an infectious disease that usually affects dogs with immune deficiencies, but can eventually regress without treatment. However, this regression without treatment can be time-consuming, taking up to 12 months for complete regression, thus causing more suffering for the dogs and difficulties in the maintenance and hygiene of the animal. Many treatments have been proposed, but most without scientific references, which has often led to frustrating results. The aim of this report is to describe the response to the treatment of one bitch with oral papillomatosis, using Azithromycin associated with Meloxicam.
Case: A 6-month-old bitch Pug with skin lesions consistent with canine oral papillomatosis, presenting typical clinical lesions such as exophytic vegetative formations, cauliflower-like lesions and verrucous and hyperkeratotic papules around the mouth and on the internal oral mucosa. The treatment protocol included Azithromycin (10 mg/kg) in combination with Meloxicam (0.1 mg/kg), administered orally every 24 h for 10 days. This therapeutic management protocol was in accordance with the dosage recommendations provided by the manufacturer of the drug approved and commercially available in Brazil. The dog maintained normal appetite and behavior and showed no clinical signs other than the aforementioned lesions. This treatment resulted in complete resolution of the papillomatous lesions. Follow-up monitoring over 12 months showed no recurrence, indicating sustained clinical remission.
Discussion: Azithromycin is widely used in Veterinary Medicine to treat various bacterial infections, and it is well tolerated and effective in treating papillomatosis in humans; however, the precise mechanism of its antiviral activity is not fully understood. In the present case, the lesions completely regressed after 10 days of treatment with Azithromycin and Meloxicam. Possibly Meloxicam improved the dog's quality of life during treatment by reducing the discomfort associated with the oral lesions, since other studies have shown that Meloxicam was effective in vitro in reducing cell proliferation, inducing apoptosis and improving the human patient's quality of life by relieving the pain and discomfort caused by the papillomatosis lesions. The combined treatment of Azithromycin and Meloxicam carried out in this case was effective for the rapid resolution of canine oral papillomatosis and without recurrence, indicating sustained clinical remission. Effective treatment is particularly important to avoid a prolonged course of the disease, which can increase the spread of the infection to other dogs. Tumor recurrence after apparently successful treatment is also common and, in addition, the possible malignancy of papillomatous lesions requires prompt and effective treatment. Reducing the incidence of clinical cases of oral papillomatosis in dogs requires strategic management, including appropriate treatment to contain the spread of the virus. Further studies are needed to investigate any specific antiviral activity of these two drugs used on the dog in the present report.
Keywords: dog, papillomavirus, wart, disease.
Downloads
References
Ali S.K. & Abdulkarim S. 2018. Treatment of Anal Cancer PaindA Case Report. Journal of Pain and Symptom Management. 56(1): e1-e2. DOI: 10.1016/j.jpainsymman.2018.03.021 DOI: https://doi.org/10.1016/j.jpainsymman.2018.03.021
Arantes-Rodrigues R., Pinto-Leite R., Ferreira R., Neuparth M.J., Pires M.J., Gaivão I., Palmeira C., Santos L., Colaço A. & Oliveira P. 2013. Meloxicam in the treatment of in vitro and in vivo models of urinary bladder cancer. Biomedicine & Pharmacotherapy. 67(4): 277-284. DOI: 10.1016/j.biopha.2013.01.010 DOI: https://doi.org/10.1016/j.biopha.2013.01.010
Atasoy M., Ozdemir S., Aktas A., Aliagaoglu C., Karakuzu A. & Erdem T. 2004. Treatment of confluent and reticulated papillomatosis with azithromycin. The Journal of Dermatology. 31(8): 682-686. DOI: 10.1111/j.1346-8138.2004.tb00577.x DOI: https://doi.org/10.1111/j.1346-8138.2004.tb00577.x
Borges O.M.M., Araújo C.L.M., Ramalho G.C., Silva R.M.N., Tanikawa A. & Souza A.P. 2017. Effects of Autohemotherapy on Hematologic Parameters and Morphology of Canine Oral Papillomatosis. Acta Scientiae Veterinariae. 45(Suppl1): 211. 6p. DOI: 10.22456/1679-9216.85910 DOI: https://doi.org/10.22456/1679-9216.85910
Chang C.Y., Yamashita-Kawanishi N., Tomizawa S., Liu I.L., Chen W.T., Chang, Y.C., Huang W.H., Tsai P.S., Shirota K., Chambers J.K., Uchida K., Haga T. & Chang H.W. 2020. Whole Genomic Analysis and Comparison of Two Canine Papillomavirus Type 9 Strains in Malignant and Benign Skin Lesions. Viruses. 12(7): 736. DOI: 10.3390/v12070736 DOI: https://doi.org/10.3390/v12070736
Divya A., Manoj K., Tarun K., Parmod K., Ankit K. & Neelesh S. 2015. Successful therapeutic management of a case of canine papillomatosis. Haryana Veterinarian. 54: 79-80.
Greer K.A., Wong A.K., Liu H., Famula T.R., Pedersen N.C., Ruhe A., Wallace M. & Neff M.W. 2010. Necrotizing meningoencephalitis of Pug dogs associates with dog leukocyte antigen class II and resembles acute variant forms of multiple sclerosis. Tissue Antigens. 76(2): 110-118. DOI: 10.1111/j.1399-0039.2010.01484.x DOI: https://doi.org/10.1111/j.1399-0039.2010.01484.x
Kant S., Sinan O.Y., Mehmet K., Yakup Y., Ozlem O., Kamil A. & Sait H.S. 2023. Virological and Pathological Diagnosis of Canine Oral Papillomavirus in Dogs and Evaluation of Treatment Applications. Agricultural Science Digest. 43(4): 562-567. DOI: 10.18805/ag.DF-526 DOI: https://doi.org/10.18805/ag.DF-526
Lane H.E., Weese J.S. & Stull J.W. 2017. Canine oral papillomavirus outbreak at a dog daycare facility. The Canadian Veterinary Journal. 58(7): 747-749.
Munday J.S., Bond S.D., Piripi S., Soulsby S.J. & Knox M.A. 2024. Canis familiaris Papillomavirus Type 26: A Novel Papillomavirus of Dogs and the First Canine Papillomavirus within the Omegapapillomavirus Genus. Viruses. 16(4): 595. DOI: 10.3390/v16040595. DOI: https://doi.org/10.3390/v16040595
Munday J.S., Gedye K., Knox M.A., Ravens P. & Lin X. 2022. Genomic Characterisation of Canis familiaris Papillomavirus Type 24, a Novel Papillomavirus Associated with Extensive Pigmented Plaque Formation in a Pug Dog. Viruses. 14(11): 2357. DOI: 10.3390/v14112357 DOI: https://doi.org/10.3390/v14112357
Nagata M. & Rosenkrantz W. 2013. Cutaneous viral dermatoses in dogs and cats. Compendium. 35(7): E1.
Nicholls P.K., Klaunberg B.A., Moore R.A., Santos E.B., Parry N.R., Gough G.W. & Stanley M.A. 1999. Naturally occurring, no regressing canine oral papillomavirus infection: host immunity, virus characterization, and experimental infection. Virology. 265(2): 365-374. DOI: 10.1006/viro.1999.0060. DOI: https://doi.org/10.1006/viro.1999.0060
Orlandi M., Mazzei M., Albanese F., Pazzini L., Mei M., Lazzarini G., Forzan M., Massaro M.,Vascellari M. & Abramo F. 2023. Clinical, histopathological, and molecular characterization of canine pigmented viral plaques. Veterinary Pathology. 60(6): 857-864. DOI: 10.1177/03009858231195762 DOI: https://doi.org/10.1177/03009858231195762
Sancak A., Favrot C., Geisseler M.D., Muller M. & Lange C.E. 2015. Antibody titres against canine papillomavirus 1 peak around clinical regression in naturally occurring oral papillomatosis. Veterinary Dermatology. 26(1): 57-e-20. DOI: 10.1111/vde.12189 DOI: https://doi.org/10.1111/vde.12189
Sundberg J.P., Smith E.K., Herron A.J., Jenson A.B. Burk R.D. & Van Ranst M. 1994. Involvement of canine oral papillomavirus in generalized oral and cutaneous verrucosis in a Chinese Shar Pei dog. Veterinary Pathology. 31: 183-187. DOI: 10.1177/030098589403100204 DOI: https://doi.org/10.1177/030098589403100204
Teifke J.P, Lohr C.V. & Shirasawa H. 1998. Detection of canine oral papillomavirus- DNA in canine oral squamous cell carcinomas and p53 overexpressing skin papillomas of the dog using the polymerase chain reaction and non-radioactive in situ hybridization. Veterinary Microbiology. 60(2-4): 119-130. DOI: 10.1016/S0378-1135(98)00151-5 DOI: https://doi.org/10.1016/S0378-1135(98)00151-5
Thaiwong T., Sledge D.G., Wise A.G., Olstad K., Maes R.K. & Kiupel M. 2018. Malignant transformation of canine oral papillomavirus (CPV1)-associated papillomas in dogs: An emerging concern? Papillomavirus Research. 6: 83-89. DOI: 10.1016/j.pvr.2018.10.007 DOI: https://doi.org/10.1016/j.pvr.2018.10.007
Weigl L., Beham A., Schnopp C., Möhrenschlager M. & Abeck D. 2001. Papillomatosis confluens et reticularis Erfolgreiche Therapie mit Azithromycin. Hautarzt. 52(Suppl1): 947-949. DOI: 10.1007/s001050170004 DOI: https://doi.org/10.1007/s001050170004
Williams A., Scally G. & Langland J. 2021. A topical botanical therapy for the treatment of canine papilloma virus associated oral warts: A case series. Advances in Integrative Medicine. 8(2): 151-154. DOI: 10.1016/j.aimed.2020.12.003 DOI: https://doi.org/10.1016/j.aimed.2020.12.003
Yaǧcı B.B., Ural K., Öcal N. & Haydardedeolu A.E. 2008. Azithromycin therapy of papillomatosis in dogs: a prospective, randomized, double-blinded, placebo-controlled clinical trial. Veterinary Dermatology. 19(4): 194-198. DOI: 10.1111/j.1365-3164.2008.00674.x DOI: https://doi.org/10.1111/j.1365-3164.2008.00674.x
Yhee J.Y., Kwon B.J., Kim J.H., Yu C.H., Im K.S., Lee S.S., Lyoo S.S., Chang B.J. & Sur J.H. 2010. Characterization of canine oral papillomavirus by histopathology and genetic analysis in Korea. Journal of Veterinary Science. 11(1): 21-25. DOI: 10.4142/jvs.2010.11.1.21 DOI: https://doi.org/10.4142/jvs.2010.11.1.21
Yuan Y., Chen X.Y., Li S.M., Wei X.Y., Yao H.M. & Zhong D.F. 2009. Pharmacokinetic studies of meloxicam following oral and transdermal administration in Beagle dogs. Acta Pharmacologica Sinica. 30: 1060-1064. DOI: 10.1038/aps.2009.73 DOI: https://doi.org/10.1038/aps.2009.73
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Cristiano Barros de Melo, Gustavo Machado Jantorno, Márcio Botelho de Castro, Eduardo Maurício Mendes Lima, Eduardo Bastianetto
This work is licensed under a Creative Commons Attribution 4.0 International License.
This journal provides open access to all of its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. Such access is associated with increased readership and increased citation of an author's work. For more information on this approach, see the Public Knowledge Project and Directory of Open Access Journals.
We define open access journals as journals that use a funding model that does not charge readers or their institutions for access. From the BOAI definition of "open access" we take the right of users to "read, download, copy, distribute, print, search, or link to the full texts of these articles" as mandatory for a journal to be included in the directory.
La Red y Portal Iberoamericano de Revistas Científicas de Veterinaria de Libre Acceso reúne a las principales publicaciones científicas editadas en España, Portugal, Latino América y otros países del ámbito latino
